Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
umbilical cord mesenchymal stem cells (South China Institute for Stem Cell Biology and Regenerative Medicine)
- Development stage
- Unknown
- Lead developer
- Platinumlife Biotech
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intraarticular
01
Overview
Umbilical cord mesenchymal stem cells (UCMSCs) are a type of multipotent stem cell being developed by the South China Research Center for Stem Cell and Regenerative Medicine for the treatment of articular cartilage defects and knee osteoarthritis. These cells are harvested from the umbilical cord tissue and possess the ability to differentiate into various lineages, including chondrocytes, which are essential for cartilage repair. Beyond direct differentiation, UCMSCs exert therapeutic effects through paracrine signaling, secreting a variety of cytokines, growth factors, and extracellular vesicles that modulate the immune response, reduce local inflammation, and stimulate endogenous tissue repair mechanisms within the joint. This specific cell therapy is being evaluated in Phase I/II clinical trials to determine its safety and efficacy in regenerating damaged cartilage and improving functional outcomes in patients with degenerative joint diseases.
- Other names
- human umbilical cord mesenchymal stem cellsumbilical cord-derived mesenchymal stem cells
Beyond the preview
Go deeper on umbilical cord mesenchymal stem cells (South China Institute for Stem Cell Biology and Regenerative Medicine).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on umbilical cord mesenchymal stem cells (South China Institute for Stem Cell Biology and Regenerative Medicine).